Recently Issued FDA Update
- Posted on: Sep 13 2022
FDA Safe Communication about Breast Implants
The U.S. Food and Drug Administration (FDA) has recently published a safe communication about breast implants to inform the public about reports of cancers, including squamous cell carcinoma (SCC) and and ALCL in the capsule that forms around breast implants. The FDA learned about these reports through their continual post market review of breast implants and ongoing collaboration with external stakeholders.
The information was published only last week and there is no further information at this point; the FDA is just asking health care providers and people with breast implants to report cases of SCC, lymphomas, or any other cancers around the breast implant to the FDA.
Posted in: Marketing